The Market Reports

Synopsis
The global market for Albumin was estimated to be worth US$ 6888 million in 2024 and is forecast to a readjusted size of US$ 10580 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
The albumin market is driven by the rising prevalence of liver diseases, kidney disorders, and hypoproteinemia, which require albumin therapy. Additionally, the growing use of albumin in critical care, such as treating burns, shock, and sepsis, is fueling demand. Expanding applications in drug delivery, vaccine formulation, and regenerative medicine are also key factors driving market growth. Moreover, the increasing geriatric population and advancements in recombinant and synthetic albumin production are expected to boost market expansion, particularly in developed healthcare markets.
However, the market faces challenges such as high production costs and supply constraints, particularly for human serum albumin, which relies on plasma collection. Stringent regulatory approvals for plasma-derived products and concerns regarding pathogen transmission further hinder market growth. Additionally, competition from alternative therapies, including synthetic colloids and plant-based albumin substitutes, may impact demand. Market players must address supply chain limitations, invest in recombinant albumin production, and navigate complex regulatory landscapes to sustain growth in this competitive industry.
This report aims to provide a comprehensive presentation of the global market for Albumin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Albumin by region & country, by Type, and by Application.
The Albumin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albumin.
Market Segmentation
By Company
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Sartorius
Tiantan Bio
Pailin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Thermo Fisher
Merck
Cytiva
Proliant Biologicals
Segment by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Segment by Application
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Albumin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index